Respiratory Disease Genetic Testing Market Size, Share & Trends Analysis Report By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type, By Offerings (PCR, NGS (Whole Genome Sequencing, Whole Exome Sequencing), Others, By Trait Type (Inherited Trait, Acquired Trait), By Age Group, By End-User, By Region, And By Segment Forecasts, 2023-2031
Segmentation of Respiratory Disease Genetic Testing Market-
By Offerings
- Products
- Kits and Consumables
- Services
- Others
By Disease Type
- COPD (Alpha-1-antitrypsin (AAT)
- Cystic Fibrosis (CF)
- Diffuse Lung Disease/Surfactant Dysfunction
- RHD (Respiratory Distress Syndrome)
- PPHN (Persistent Pulmonary Hypertension of the Newborn)
- Interstitial lung disease
- Pulmonary Arterial Hypertension
- Pulmonary Hypoplasia
- Primary Ciliary Dyskinesia
- Other Diseases (BPD)
By Technology
- PCR
- NGS
- Whole Genome Sequencing
- Whole Exome Sequencing
- Others (Targeted Sequencing, Karyotyping, and FISH)
By Trait Type
- Inherited Trait
- Acquired Trait
By Age Group
- Children
- Adult
By End-User
- Hospital Laboratories
- Diagnostics Laboratories
- Genetic Testing Laboratories
- Research Laboratories
- Other End User
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Respiratory Disease Genetic Testing Market Snapshot
Chapter 4. Global Respiratory Disease Genetic Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Trait Type Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Offering:
5.2.1. Products
5.2.1.1. Kits and Consumables
5.2.2. Services
5.2.3. Others
Chapter 6. Market Segmentation 2: By Specialty Type Estimates & Trend Analysis
6.1. By Specialty Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Specialty Type:
6.2.1. COPD (Alpha-1-antitrypsin (AAT)
6.2.2. Cystic Fibrosis (CF)
6.2.3. Diffuse Lung Disease/Surfactant Dysfunction
6.2.3.1. RHD (Respiratory Distress Syndrome)
6.2.3.2. PPHN (Persistent Pulmonary Hypertension of the Newborn)
6.2.4. Interstitial lung disease
6.2.5. Pulmonary Arterial Hypertension
6.2.6. Pulmonary Hypoplasia
6.2.7. Primary Ciliary Dyskinesia
6.2.8. Other Diseases (BPD)
Chapter 7. Market Segmentation 3: By Trait Type Estimates & Trend Analysis
7.1. By Trait Type & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Trait Type:
7.2.1. Inherited Trait
7.2.2. Acquired Trait
Chapter 8. Market Segmentation 4: By Test Type Technology Estimates & Trend Analysis
8.1. By Test Type Technology & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Test Type Technology:
8.2.1. PCR
8.2.2. NGS
8.2.2.1. Whole Genome Sequencing
8.2.2.2. Whole Exome Sequencing
8.2.3. Others (Targeted Sequencing, Karyotyping, and FISH)
Chapter 9. Market Segmentation 5: By Age Group Estimates & Trend Analysis
9.1. By Age Group & Market Share, 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Age Group:
9.2.1. Children Age Group
9.2.2. Adult Age Group
Chapter 10. Market Segmentation 6: By End User Estimates & Trend Analysis
10.1. By End User & Market Share, 2020 & 2031
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
10.2.1. Hospital Laboratories
10.2.2. Diagnostics Laboratories
10.2.3. Genetic Testing Laboratories
10.2.4. Research Laboratories
10.2.5. Other End User
Chapter 11. Respiratory Disease Genetic Testing Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Offering, 2019-2031
11.1.2. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Specialty Type, 2019-2031
11.1.3. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Trait Type, 2019-2031
11.1.4. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Test Type Technology, 2019-2031
11.1.5. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031
11.1.6. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
11.1.7. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
11.2. Europe
11.2.1. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031
11.2.2. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031
11.2.3. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031
11.2.4. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031
11.2.5. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031
11.2.6. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031
11.2.7. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031
11.3.2. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031
11.3.3. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031
11.3.4. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031
11.3.5. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031
11.3.6. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031
11.3.7. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.4. Latin America
11.4.1. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031
11.4.2. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031
11.4.3. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031
11.4.4. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031
11.4.5. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
11.4.6. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User (US$ Million) 2019-2031
11.4.7. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031
11.5.2. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031
11.5.3. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031
11.5.4. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031
11.5.5. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
11.5.6. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
11.5.7. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. 23andMe, Inc.
12.2.2. Centogene A.G.
12.2.3. GeneDx, Inc.
12.2.4. Invitae Corporation
12.2.5. Color Genomics
12.2.6. Myriad Genetics
12.2.7. Medicover Genetics
12.2.8. Blueprint Genetics
12.2.9. Prevention Genetics
12.2.10. Quest Diagnostics
12.2.11. Genesis Genetics
12.2.12. ARUP Laboratories
12.2.13. EGL Genetic Diagnostics
12.2.14. Laboratory Corporation of America Holdings (LabCorp)
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Respiratory Disease Genetic Testing Market Size is predicted to witness a 5.34% CAGR during the forecast period for 2023-2031.
Genesis Genetics, ARUP Laboratories, EGL Genetic Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Others
Offerings, disease type, technology, trait type, age group and end-user are the key segments of the Respiratory Disease Genetic Testing Market.
North American region is leading the Respiratory Disease Genetic Testing Market.